NFKB1 and frontotemporal dementia: Using IMS-088 to inhibit the canonical NF-κB pathway, we demonstrate that reducing pro-inflammatory signals has an overall therapeutic effect on the reversal of ALS/FTD associated phenotypes observed in our models (Figs. 5, 6, 7 and 8).